Is BXEAX or JNJ a better dividend investment in 2026?

BXEAX currently yields 99.98% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: BXEAX offers higher current income.

What is the dividend yield difference between BXEAX and JNJ?

BXEAX has a forward dividend yield of 99.98% ($7.60/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 96.62 percentage points.

Home › Compare › BXEAX vs JNJ

BXEAX vs JNJ: Dividend Comparison 2026

BXEAX yields 99.98% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BXEAX wins by $3.87M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BXEAX

● Live price

99.98%

Share price

$7.60

Annual div

$7.60

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3.89M

Annual income

$1,311,551.55

Full BXEAX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — BXEAX vs JNJ

📍 BXEAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BXEAX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BXEAX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BXEAX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BXEAX

Annual income on $10K today (after 15% tax)

$8,498.10/yr

After 10yr DRIP, annual income (after tax)

$1,114,818.82/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, BXEAX beats the other by $1,114,115.20/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BXEAX + JNJ for your $10,000?

BXEAX: 50%JNJ: 50%

100% JNJ50/50100% BXEAX

Portfolio after 10yr

$1.96M

Annual income

$656,189.67/yr

Blended yield

33.55%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BXEAX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BXEAX buys

JNJ buys

No recent congressional trades found for BXEAX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBXEAXJNJ

Forward yield	99.98% ✓	3.36%
Annual dividend / share	$7.60 ✓	$4.96
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$3.89M	$20.0K ✓
Annual income after 10y	$1,311,551.55 ✓	$827.78
Total dividends collected	$3.48M	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BXEAX vs JNJ ($10,000, DRIP)

Year	BXEAX Portfolio	BXEAX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$20,698	$9,997.76	$10,676	$355.77	+$10.0K → BXEAX
2	$41,486	$19,339.38	$11,407	$389.39	+$30.1K → BXEAX
3	$80,617	$36,227.36	$12,198	$426.53	+$68.4K → BXEAX
4	$152,054	$65,793.07	$13,056	$467.62	+$139.0K → BXEAX
5	$278,672	$115,975.06	$13,987	$513.12	+$264.7K → BXEAX
6	$496,825	$198,645.19	$14,998	$563.56	+$481.8K → BXEAX
7	$862,584	$330,981.26	$16,098	$619.52	+$846.5K → BXEAX
8	$1,460,018	$537,053.66	$17,295	$681.69	+$1.44M → BXEAX
9	$2,411,773	$849,553.87	$18,599	$750.82	+$2.39M → BXEAX
10	$3,892,149	$1,311,551.55	$20,022	$827.78	+$3.87M → BXEAX

BXEAX vs JNJ: Complete Analysis 2026

BXEAX — Stock

The fund will invest at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in (i) securities denominated in currencies of the emerging market countries, (ii) fixed income securities or debt instruments issued by emerging market entities or sovereign nations, and/or (iii) debt instruments denominated in or based on the currencies, interest rates, or issues of emerging market countries.

Full BXEAX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this BXEAX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BXEAX vs SCHD BXEAX vs JEPI BXEAX vs O BXEAX vs KO BXEAX vs MAIN BXEAX vs ABBV BXEAX vs MRK BXEAX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.